reported that high-dose intravenous administration of a COVID-19 mRNA vaccine in BALB/c mice induced multifocal myocarditis and pericarditis, accompanied by elevated cardiac interleukin-6 (IL-6) and additional proinflammatory markers, indicative of a robust systemic inflammatory response (15). The gene discussed is IL6; the disease is myocarditis.